Watch DFTX. Know when insiders buy.
One email the day a filing lands. Free.
DFTX
Definium Therapeutics, Inc.
35.49
+0.40 +1.14%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
27
FLAG · insiders 25, shorts 28
Insiders, 90 days
−$3M
net selling · 0 buys, 6 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $4.8BP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$353.8MNET CASH $618.8M52W 10.68 – 48.45SEC XBRL · TTM TO Invalid Date
Insider trading
−$3M
Net, 90 days
0 / 6
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 25 | Sep 29 | Karlin Daniel · Chief Medical Officer | Sell | 10,853 | $36.57 | $397K |
| Sep 25 | Sep 29 | Wiley Matthew T. · Chief Commercial Officer | Sell | 3,097 | $36.57 | $113K |
| Sep 25 | Sep 29 | Sullivan Mark · Chief Legal Officer | Sell | 14,051 | $36.57 | $514K |
| Sep 25 | Sep 29 | Roberts Brandi · Chief Financial Officer | Sell | 3,377 | $36.57 | $123K |
| Sep 25 | Sep 29 | Barrow Robert · Chief Executive Officer | Sell | 31,550 | $36.57 | $1.2M |
| Sep 3 | Sep 4 | Barrow Robert · Chief Executive Officer | Sell | 19,023 | $37.94 | $722K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.